Radiotherapy Combined With Endostatin and Capecitabine for NPC

Clinical trial NCT05514275 · RECRUITING

Trial details

NCT number: NCT05514275
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2022-08-01
Primary completion: 2026-08-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.